Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 2 of 2497 results
Sort by: relevance publication year
Showing results for ISSN matching 1472-8222

JOURNAL ISSUE published March 2007 in Expert Opinion on Therapeutic Targets

https://doi.org/10.1517/ett.2007.11.issue-3 Actions

Related articles

JOURNAL ARTICLE published 3 April 2015 in Expert Opinion on Therapeutic Targets

https://doi.org/10.1517/14728222.2015.1026094 Actions

JOURNAL ISSUE published December 1998 in Expert Opinion on Therapeutic Targets

https://doi.org/10.1517/ett.1998.2.issue-2 Actions

Molecular targets for selective killing of TRAIL-resistant leukemic cells

JOURNAL ARTICLE published August 2011 in Expert Opinion on Therapeutic Targets

Authors: Giorgio Zauli | Raffaella Bosco | Paola Secchiero

https://doi.org/10.1517/14728222.2011.580278 Actions

JOURNAL ISSUE published April 2008 in Expert Opinion on Therapeutic Targets

https://doi.org/10.1517/ett.2008.12.issue-4 Actions

JARID1/KDM5 demethylases as cancer targets?

JOURNAL ARTICLE published 2 January 2017 in Expert Opinion on Therapeutic Targets

Authors: Joyce Taylor-Papadimitriou | Joy Burchell

https://doi.org/10.1080/14728222.2017.1263616 Actions

The therapeutic potential of regulatory T cells for the treatment of autoimmune disease

JOURNAL ARTICLE published 3 August 2015 in Expert Opinion on Therapeutic Targets

Authors: Jeffrey A Bluestone | Eleonora Trotta | Daqi Xu

https://doi.org/10.1517/14728222.2015.1037282 Actions

Novel ion channel targets in atrial fibrillation

JOURNAL ARTICLE published 2 August 2016 in Expert Opinion on Therapeutic Targets

Research funded by Else Kröner-Fresenius-Stiftung (2014_A242) | German Foundation of Heart Research (F/08/14)

Authors: Jules C. Hancox | Andrew F. James | Neil V. Marrion | Henggui Zhang | Dierk Thomas

https://doi.org/10.1517/14728222.2016.1159300 Actions

Germline copy number variation in theYTHDC2gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

JOURNAL ARTICLE published August 2014 in Expert Opinion on Therapeutic Targets

Authors: Daniele Fanale | Juan Lucio Iovanna | Ezequiel Luis Calvo | Patrice Berthezene | Pascal Belleau | Jean Charles Dagorn | Giuseppe Bronte | Giuseppe Cicero | Viviana Bazan | Christian Rolfo | Daniele Santini | Antonio Russo

https://doi.org/10.1517/14728222.2014.920324 Actions

Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy

JOURNAL ARTICLE published 3 October 2015 in Expert Opinion on Therapeutic Targets

Authors: Helen HW Chen | Wen-Chung Chen | Zhang-Dong Liang | Wen-Bin Tsai | Yan Long | Isamu Aiba | Siqing Fu | Russell Broaddus | Jinsong Liu | Lynn G Feun | Niramol Savaraj | Macus Tien Kuo

https://doi.org/10.1517/14728222.2015.1043269 Actions

Mitochondria makeover: unlocking the path to healthy longevity

JOURNAL ARTICLE published 2 November 2023 in Expert Opinion on Therapeutic Targets

Authors: Andrés Caicedo | Keshav K. Singh

https://doi.org/10.1080/14728222.2023.2277240 Actions

Topiramate and Type 2 diabetes: an old wine in a new bottle

JOURNAL ARTICLE published January 2008 in Expert Opinion on Therapeutic Targets

Authors: Vivek Khanna | Surendar Arumugam | Subhasis Roy | Shivani Mittra | Vinay S Bansal

https://doi.org/10.1517/14728222.12.1.81 Actions

Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases – potentially novel therapeutic targets

JOURNAL ARTICLE published 3 October 2018 in Expert Opinion on Therapeutic Targets

Research funded by National Cancer Institute (R35 CA197582)

Authors: Yoshihiro Ito | Jonathan R. Hart | Peter K. Vogt

https://doi.org/10.1080/14728222.2018.1522302 Actions

A diversity of therapeutic targets

JOURNAL ARTICLE published June 2002 in Expert Opinion on Therapeutic Targets

Authors: Nafsika H Georgopapadakou

https://doi.org/10.1517/14728222.6.3.255 Actions

Most cancer can be prevented: we can do more

JOURNAL ARTICLE published March 2012 in Expert Opinion on Therapeutic Targets

Authors: Tai Hing Lam

https://doi.org/10.1517/14728222.2011.640321 Actions

Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain

JOURNAL ARTICLE published August 2009 in Expert Opinion on Therapeutic Targets

Authors: Perumal Yogeeswari | Arvind Semwal | Ramkumar Mishra | Dharmarajan Sriram

https://doi.org/10.1517/14728220903029210 Actions

Drug Discovery and Development for Inflammatory Diseases

JOURNAL ARTICLE published 2004 in Expert Opinion on Therapeutic Targets

Authors: Carl K Edwards

https://doi.org/10.1517/eott.8.2.151.30245 Actions

Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases?

JOURNAL ARTICLE published December 2004 in Expert Opinion on Therapeutic Targets

Authors: Charles N Serhan

https://doi.org/10.1517/14728222.8.6.643 Actions

New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease

JOURNAL ARTICLE published 2 June 2020 in Expert Opinion on Therapeutic Targets

Authors: Thijs R. M. Barten | Lucas H. P. Bernts | Joost P. H. Drenth | Tom J. G. Gevers

https://doi.org/10.1080/14728222.2020.1751818 Actions

Epigenomic targets for the treatment of respiratory disease

JOURNAL ARTICLE published June 2009 in Expert Opinion on Therapeutic Targets

Authors: Rayleen V Bowman | Casey M Wright | Morgan R Davidson | Santiyagu M Savarimuthu Francis | Ian A Yang | Kwun M Fong

https://doi.org/10.1517/14728220902926119 Actions
Feedback: support@crossref.org